Alvandi, F., Kwitkowski, V. E., Ko, C., Rothmann, M. D., Ricci, S., Saber, H., . . . Pazdur, R. (2014). U.S. Food and Drug Administration Approval Summary: Omacetaxine Mepesuccinate as Treatment for Chronic Myeloid Leukemia. AlphaMed Press.
استشهاد بنمط شيكاغوAlvandi, Firoozeh, et al. U.S. Food and Drug Administration Approval Summary: Omacetaxine Mepesuccinate As Treatment for Chronic Myeloid Leukemia. AlphaMed Press, 2014.
MLA استشهادAlvandi, Firoozeh, et al. U.S. Food and Drug Administration Approval Summary: Omacetaxine Mepesuccinate As Treatment for Chronic Myeloid Leukemia. AlphaMed Press, 2014.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.